Search tips
Search criteria 


Logo of jroyalcgpracBJGP at RCGPBJGP at PubMed CentralJ R Coll Gen Pract at PubMed CentralRCGP homepage
J R Coll Gen Pract. 1977 December; 27(185): 742–745.
PMCID: PMC2158659

Once daily sotalol in the treatment of hypertension


In a small group of hypertensive patients studied at home, once daily early morning sotalol therapy effectively decreased lying, standing, and post-exercise blood pressure and pulse rate. A dose-response relationship was seen. Adverse effects were mild and transient. The once daily regimen is easy to administer and appears to give precision in blood pressure reduction. Providing there is no subsequent escape from control, once daily beta-blocking therapy should aid long-term hypertension treatment in general practice.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (651K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Blackwell B. Drug therapy: patient compliance. N Engl J Med. 1973 Aug 2;289(5):249–252. [PubMed]
  • Brown P, Baddeley H, Read AE, Davies JD, McGarry J. Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol). Lancet. 1974 Dec 21;2(7895):1477–1481. [PubMed]
  • Douglas-Jones AP, Cruickshank JM. Once-daily dosing with Atenolol in patients with mild or moderate hypertension. Br Med J. 1976 Apr 24;1(6016):990–991. [PMC free article] [PubMed]
  • Felix RH, Ive FA, Dahl MG. Cutaneous and ocular reactions to practolol. Br Med J. 1974 Nov 9;4(5940):321–324. [PMC free article] [PubMed]
  • Frithz Göran. Once-daily treatment of hypertension. Br Med J. 1976 Oct 09;2(6040):c877–877. [PMC free article]
  • Gatley MS. To be taken as directed. J R Coll Gen Pract. 1968 Jul;16(1):39–44. [PMC free article] [PubMed]
  • Gross F. Drug therapy of hypertension: what we have, what we need, what we expect. Am J Cardiol. 1974 Oct 1;34(4):471–475. [PubMed]
  • Harris AM, Wollard KV, Tweed JA. A study of once daily tenormin (atenolol) in hypertension: some implications in patient compliance. J Int Med Res. 1976;4(5):347–351. [PubMed]
  • Lish PM, Weikel JH, Dungan KW. Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists. J Pharmacol Exp Ther. 1965 Aug;149(2):161–173. [PubMed]
  • Petrie JC. Diseases of the cardiovascular system. Hypertension--I. Br Med J. 1976 Jul 31;2(6030):289–291. [PMC free article] [PubMed]
  • PRICHARD BN, GILLAM PM. USE OF PROPRANOLOL (INDERAL) IN TREATMENT OF HYPERTENSION. Br Med J. 1964 Sep 19;2(5411):725–727. [PMC free article] [PubMed]
  • Simpson FO. Beta-adrenergic receptor blocking drugs in hypertension. Drugs. 1974;7(1):85–105. [PubMed]
  • Woolfson AMJ, Knapp MS. Once-daily treatment of hypertension. Br Med J. 1976 Jul 24;2(6029):c235–235. [PMC free article]
  • Wright P. Untoward effects associated with practolol administration: oculomucocutaneous syndrome. Br Med J. 1975 Mar 15;1(5958):595–598. [PMC free article] [PubMed]

Articles from The Journal of the Royal College of General Practitioners are provided here courtesy of Royal College of General Practitioners